ICD-10-CM/PCS MS-DRG v41.1 Definitions Manual
Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
MDC 21 Injuries, poisonings and toxic effects of drugs
Poisoning and toxic effects of drugs
Page 2 of 4

PRINCIPAL DIAGNOSIS (continued)

M1A10X0 T4274XA T492X5A T604X2A

T4274XAPoisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
T4275XAAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T428X1APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), initial encounter
T428X2APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter
T428X3APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, initial encounter
T428X4APoisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, initial encounter
T428X5AAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
T43011APoisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
T43012APoisoning by tricyclic antidepressants, intentional self-harm, initial encounter
T43013APoisoning by tricyclic antidepressants, assault, initial encounter
T43014APoisoning by tricyclic antidepressants, undetermined, initial encounter
T43015AAdverse effect of tricyclic antidepressants, initial encounter
T43021APoisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
T43022APoisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
T43023APoisoning by tetracyclic antidepressants, assault, initial encounter
T43024APoisoning by tetracyclic antidepressants, undetermined, initial encounter
T43025AAdverse effect of tetracyclic antidepressants, initial encounter
T431X1APoisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
T431X2APoisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
T431X3APoisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
T431X4APoisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
T431X5AAdverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43201APoisoning by unspecified antidepressants, accidental (unintentional), initial encounter
T43202APoisoning by unspecified antidepressants, intentional self-harm, initial encounter
T43203APoisoning by unspecified antidepressants, assault, initial encounter
T43204APoisoning by unspecified antidepressants, undetermined, initial encounter
T43205AAdverse effect of unspecified antidepressants, initial encounter
T43211APoisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
T43212APoisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
T43213APoisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
T43214APoisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
T43215AAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43221APoisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
T43222APoisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
T43223APoisoning by selective serotonin reuptake inhibitors, assault, initial encounter
T43224APoisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
T43225AAdverse effect of selective serotonin reuptake inhibitors, initial encounter
T43291APoisoning by other antidepressants, accidental (unintentional), initial encounter
T43292APoisoning by other antidepressants, intentional self-harm, initial encounter
T43293APoisoning by other antidepressants, assault, initial encounter
T43294APoisoning by other antidepressants, undetermined, initial encounter
T43295AAdverse effect of other antidepressants, initial encounter
T433X1APoisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T433X2APoisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
T433X3APoisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
T433X4APoisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
T433X5AAdverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
T434X1APoisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
T434X2APoisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
T434X3APoisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
T434X4APoisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
T434X5AAdverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T43501APoisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43502APoisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43503APoisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
T43504APoisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
T43505AAdverse effect of unspecified antipsychotics and neuroleptics, initial encounter
T43591APoisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43592APoisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43593APoisoning by other antipsychotics and neuroleptics, assault, initial encounter
T43594APoisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
T43595AAdverse effect of other antipsychotics and neuroleptics, initial encounter
T43601APoisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
T43602APoisoning by unspecified psychostimulants, intentional self-harm, initial encounter
T43603APoisoning by unspecified psychostimulants, assault, initial encounter
T43604APoisoning by unspecified psychostimulants, undetermined, initial encounter
T43605AAdverse effect of unspecified psychostimulants, initial encounter
T43611APoisoning by caffeine, accidental (unintentional), initial encounter
T43612APoisoning by caffeine, intentional self-harm, initial encounter
T43613APoisoning by caffeine, assault, initial encounter
T43614APoisoning by caffeine, undetermined, initial encounter
T43615AAdverse effect of caffeine, initial encounter
T43621APoisoning by amphetamines, accidental (unintentional), initial encounter
T43622APoisoning by amphetamines, intentional self-harm, initial encounter
T43623APoisoning by amphetamines, assault, initial encounter
T43624APoisoning by amphetamines, undetermined, initial encounter
T43625AAdverse effect of amphetamines, initial encounter
T43631APoisoning by methylphenidate, accidental (unintentional), initial encounter
T43632APoisoning by methylphenidate, intentional self-harm, initial encounter
T43633APoisoning by methylphenidate, assault, initial encounter
T43634APoisoning by methylphenidate, undetermined, initial encounter
T43635AAdverse effect of methylphenidate, initial encounter
T43641APoisoning by ecstasy, accidental (unintentional), initial encounter
T43642APoisoning by ecstasy, intentional self-harm, initial encounter
T43643APoisoning by ecstasy, assault, initial encounter
T43644APoisoning by ecstasy, undetermined, initial encounter
T43651APoisoning by methamphetamines accidental (unintentional), initial encounter
T43652APoisoning by methamphetamines intentional self-harm, initial encounter
T43653APoisoning by methamphetamines, assault, initial encounter
T43654APoisoning by methamphetamines, undetermined, initial encounter
T43655AAdverse effect of methamphetamines, initial encounter
T43691APoisoning by other psychostimulants, accidental (unintentional), initial encounter
T43692APoisoning by other psychostimulants, intentional self-harm, initial encounter
T43693APoisoning by other psychostimulants, assault, initial encounter
T43694APoisoning by other psychostimulants, undetermined, initial encounter
T43695AAdverse effect of other psychostimulants, initial encounter
T438X1APoisoning by other psychotropic drugs, accidental (unintentional), initial encounter
T438X2APoisoning by other psychotropic drugs, intentional self-harm, initial encounter
T438X3APoisoning by other psychotropic drugs, assault, initial encounter
T438X4APoisoning by other psychotropic drugs, undetermined, initial encounter
T438X5AAdverse effect of other psychotropic drugs, initial encounter
T4391XAPoisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
T4392XAPoisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
T4393XAPoisoning by unspecified psychotropic drug, assault, initial encounter
T4394XAPoisoning by unspecified psychotropic drug, undetermined, initial encounter
T4395XAAdverse effect of unspecified psychotropic drug, initial encounter
T440X1APoisoning by anticholinesterase agents, accidental (unintentional), initial encounter
T440X2APoisoning by anticholinesterase agents, intentional self-harm, initial encounter
T440X3APoisoning by anticholinesterase agents, assault, initial encounter
T440X4APoisoning by anticholinesterase agents, undetermined, initial encounter
T440X5AAdverse effect of anticholinesterase agents, initial encounter
T441X1APoisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter
T441X2APoisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter
T441X3APoisoning by other parasympathomimetics [cholinergics], assault, initial encounter
T441X4APoisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter
T441X5AAdverse effect of other parasympathomimetics [cholinergics], initial encounter
T442X1APoisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
T442X2APoisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
T442X3APoisoning by ganglionic blocking drugs, assault, initial encounter
T442X4APoisoning by ganglionic blocking drugs, undetermined, initial encounter
T442X5AAdverse effect of ganglionic blocking drugs, initial encounter
T443X1APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter
T443X2APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter
T443X3APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
T443X4APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
T443X5AAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T444X1APoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
T444X2APoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
T444X3APoisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
T444X4APoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
T444X5AAdverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T445X1APoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
T445X2APoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
T445X3APoisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter
T445X4APoisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter
T445X5AAdverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
T446X1APoisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter
T446X2APoisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter
T446X3APoisoning by alpha-adrenoreceptor antagonists, assault, initial encounter
T446X4APoisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter
T446X5AAdverse effect of alpha-adrenoreceptor antagonists, initial encounter
T447X1APoisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter
T447X2APoisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter
T447X3APoisoning by beta-adrenoreceptor antagonists, assault, initial encounter
T447X4APoisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter
T447X5AAdverse effect of beta-adrenoreceptor antagonists, initial encounter
T448X1APoisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter
T448X2APoisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter
T448X3APoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter
T448X4APoisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter
T448X5AAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44901APoisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
T44902APoisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
T44903APoisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter
T44904APoisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter
T44905AAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44991APoisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
T44992APoisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
T44993APoisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter
T44994APoisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter
T44995AAdverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T450X1APoisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T450X2APoisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T450X3APoisoning by antiallergic and antiemetic drugs, assault, initial encounter
T450X4APoisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T450X5AAdverse effect of antiallergic and antiemetic drugs, initial encounter
T451X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
T451X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
T451X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
T451X4APoisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T451X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T452X1APoisoning by vitamins, accidental (unintentional), initial encounter
T452X2APoisoning by vitamins, intentional self-harm, initial encounter
T452X3APoisoning by vitamins, assault, initial encounter
T452X4APoisoning by vitamins, undetermined, initial encounter
T452X5AAdverse effect of vitamins, initial encounter
T453X1APoisoning by enzymes, accidental (unintentional), initial encounter
T453X2APoisoning by enzymes, intentional self-harm, initial encounter
T453X3APoisoning by enzymes, assault, initial encounter
T453X4APoisoning by enzymes, undetermined, initial encounter
T453X5AAdverse effect of enzymes, initial encounter
T454X1APoisoning by iron and its compounds, accidental (unintentional), initial encounter
T454X2APoisoning by iron and its compounds, intentional self-harm, initial encounter
T454X3APoisoning by iron and its compounds, assault, initial encounter
T454X4APoisoning by iron and its compounds, undetermined, initial encounter
T454X5AAdverse effect of iron and its compounds, initial encounter
T45511APoisoning by anticoagulants, accidental (unintentional), initial encounter
T45512APoisoning by anticoagulants, intentional self-harm, initial encounter
T45513APoisoning by anticoagulants, assault, initial encounter
T45514APoisoning by anticoagulants, undetermined, initial encounter
T45515AAdverse effect of anticoagulants, initial encounter
T45521APoisoning by antithrombotic drugs, accidental (unintentional), initial encounter
T45522APoisoning by antithrombotic drugs, intentional self-harm, initial encounter
T45523APoisoning by antithrombotic drugs, assault, initial encounter
T45524APoisoning by antithrombotic drugs, undetermined, initial encounter
T45525AAdverse effect of antithrombotic drugs, initial encounter
T45601APoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45602APoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45603APoisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter
T45604APoisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter
T45605AAdverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45611APoisoning by thrombolytic drug, accidental (unintentional), initial encounter
T45612APoisoning by thrombolytic drug, intentional self-harm, initial encounter
T45613APoisoning by thrombolytic drug, assault, initial encounter
T45614APoisoning by thrombolytic drug, undetermined, initial encounter
T45615AAdverse effect of thrombolytic drugs, initial encounter
T45621APoisoning by hemostatic drug, accidental (unintentional), initial encounter
T45622APoisoning by hemostatic drug, intentional self-harm, initial encounter
T45623APoisoning by hemostatic drug, assault, initial encounter
T45624APoisoning by hemostatic drug, undetermined, initial encounter
T45625AAdverse effect of hemostatic drug, initial encounter
T45691APoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45692APoisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45693APoisoning by other fibrinolysis-affecting drugs, assault, initial encounter
T45694APoisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
T45695AAdverse effect of other fibrinolysis-affecting drugs, initial encounter
T457X1APoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
T457X2APoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
T457X3APoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
T457X4APoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
T457X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T458X1APoisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
T458X2APoisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
T458X3APoisoning by other primarily systemic and hematological agents, assault, initial encounter
T458X4APoisoning by other primarily systemic and hematological agents, undetermined, initial encounter
T458X5AAdverse effect of other primarily systemic and hematological agents, initial encounter
T4591XAPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
T4592XAPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
T4593XAPoisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
T4594XAPoisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
T4595XAAdverse effect of unspecified primarily systemic and hematological agent, initial encounter
T460X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T460X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T460X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T460X4APoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T460X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T461X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T461X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
T461X3APoisoning by calcium-channel blockers, assault, initial encounter
T461X4APoisoning by calcium-channel blockers, undetermined, initial encounter
T461X5AAdverse effect of calcium-channel blockers, initial encounter
T462X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T462X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
T462X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
T462X4APoisoning by other antidysrhythmic drugs, undetermined, initial encounter
T462X5AAdverse effect of other antidysrhythmic drugs, initial encounter
T463X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
T463X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
T463X3APoisoning by coronary vasodilators, assault, initial encounter
T463X4APoisoning by coronary vasodilators, undetermined, initial encounter
T463X5AAdverse effect of coronary vasodilators, initial encounter
T464X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T464X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T464X3APoisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T464X4APoisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T464X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T465X1APoisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T465X2APoisoning by other antihypertensive drugs, intentional self-harm, initial encounter
T465X3APoisoning by other antihypertensive drugs, assault, initial encounter
T465X4APoisoning by other antihypertensive drugs, undetermined, initial encounter
T465X5AAdverse effect of other antihypertensive drugs, initial encounter
T466X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
T466X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
T466X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
T466X4APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
T466X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T467X1APoisoning by peripheral vasodilators, accidental (unintentional), initial encounter
T467X2APoisoning by peripheral vasodilators, intentional self-harm, initial encounter
T467X3APoisoning by peripheral vasodilators, assault, initial encounter
T467X4APoisoning by peripheral vasodilators, undetermined, initial encounter
T467X5AAdverse effect of peripheral vasodilators, initial encounter
T468X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T468X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
T468X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
T468X4APoisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
T468X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T46901APoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46902APoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46903APoisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
T46904APoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46991APoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46992APoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46993APoisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
T46994APoisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T470X1APoisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
T470X2APoisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
T470X3APoisoning by histamine H2-receptor blockers, assault, initial encounter
T470X4APoisoning by histamine H2-receptor blockers, undetermined, initial encounter
T470X5AAdverse effect of histamine H2-receptor blockers, initial encounter
T471X1APoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
T471X2APoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
T471X3APoisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
T471X4APoisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
T471X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T472X1APoisoning by stimulant laxatives, accidental (unintentional), initial encounter
T472X2APoisoning by stimulant laxatives, intentional self-harm, initial encounter
T472X3APoisoning by stimulant laxatives, assault, initial encounter
T472X4APoisoning by stimulant laxatives, undetermined, initial encounter
T472X5AAdverse effect of stimulant laxatives, initial encounter
T473X1APoisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
T473X2APoisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
T473X3APoisoning by saline and osmotic laxatives, assault, initial encounter
T473X4APoisoning by saline and osmotic laxatives, undetermined, initial encounter
T473X5AAdverse effect of saline and osmotic laxatives, initial encounter
T474X1APoisoning by other laxatives, accidental (unintentional), initial encounter
T474X2APoisoning by other laxatives, intentional self-harm, initial encounter
T474X3APoisoning by other laxatives, assault, initial encounter
T474X4APoisoning by other laxatives, undetermined, initial encounter
T474X5AAdverse effect of other laxatives, initial encounter
T475X1APoisoning by digestants, accidental (unintentional), initial encounter
T475X2APoisoning by digestants, intentional self-harm, initial encounter
T475X3APoisoning by digestants, assault, initial encounter
T475X4APoisoning by digestants, undetermined, initial encounter
T475X5AAdverse effect of digestants, initial encounter
T476X1APoisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
T476X2APoisoning by antidiarrheal drugs, intentional self-harm, initial encounter
T476X3APoisoning by antidiarrheal drugs, assault, initial encounter
T476X4APoisoning by antidiarrheal drugs, undetermined, initial encounter
T476X5AAdverse effect of antidiarrheal drugs, initial encounter
T477X1APoisoning by emetics, accidental (unintentional), initial encounter
T477X2APoisoning by emetics, intentional self-harm, initial encounter
T477X3APoisoning by emetics, assault, initial encounter
T477X4APoisoning by emetics, undetermined, initial encounter
T477X5AAdverse effect of emetics, initial encounter
T478X1APoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter
T478X2APoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter
T478X3APoisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter
T478X4APoisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter
T478X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T4791XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter
T4792XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter
T4793XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter
T4794XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter
T4795XAAdverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T480X1APoisoning by oxytocic drugs, accidental (unintentional), initial encounter
T480X2APoisoning by oxytocic drugs, intentional self-harm, initial encounter
T480X3APoisoning by oxytocic drugs, assault, initial encounter
T480X4APoisoning by oxytocic drugs, undetermined, initial encounter
T480X5AAdverse effect of oxytocic drugs, initial encounter
T481X1APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter
T481X2APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter
T481X3APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter
T481X4APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter
T481X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48201APoisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter
T48202APoisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter
T48203APoisoning by unspecified drugs acting on muscles, assault, initial encounter
T48204APoisoning by unspecified drugs acting on muscles, undetermined, initial encounter
T48205AAdverse effect of unspecified drugs acting on muscles, initial encounter
T48291APoisoning by other drugs acting on muscles, accidental (unintentional), initial encounter
T48292APoisoning by other drugs acting on muscles, intentional self-harm, initial encounter
T48293APoisoning by other drugs acting on muscles, assault, initial encounter
T48294APoisoning by other drugs acting on muscles, undetermined, initial encounter
T48295AAdverse effect of other drugs acting on muscles, initial encounter
T483X1APoisoning by antitussives, accidental (unintentional), initial encounter
T483X2APoisoning by antitussives, intentional self-harm, initial encounter
T483X3APoisoning by antitussives, assault, initial encounter
T483X4APoisoning by antitussives, undetermined, initial encounter
T483X5AAdverse effect of antitussives, initial encounter
T484X1APoisoning by expectorants, accidental (unintentional), initial encounter
T484X2APoisoning by expectorants, intentional self-harm, initial encounter
T484X3APoisoning by expectorants, assault, initial encounter
T484X4APoisoning by expectorants, undetermined, initial encounter
T484X5AAdverse effect of expectorants, initial encounter
T485X1APoisoning by other anti-common-cold drugs, accidental (unintentional), initial encounter
T485X2APoisoning by other anti-common-cold drugs, intentional self-harm, initial encounter
T485X3APoisoning by other anti-common-cold drugs, assault, initial encounter
T485X4APoisoning by other anti-common-cold drugs, undetermined, initial encounter
T485X5AAdverse effect of other anti-common-cold drugs, initial encounter
T486X1APoisoning by antiasthmatics, accidental (unintentional), initial encounter
T486X2APoisoning by antiasthmatics, intentional self-harm, initial encounter
T486X3APoisoning by antiasthmatics, assault, initial encounter
T486X4APoisoning by antiasthmatics, undetermined, initial encounter
T486X5AAdverse effect of antiasthmatics, initial encounter
T48901APoisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
T48902APoisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, initial encounter
T48903APoisoning by unspecified agents primarily acting on the respiratory system, assault, initial encounter
T48904APoisoning by unspecified agents primarily acting on the respiratory system, undetermined, initial encounter
T48905AAdverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48991APoisoning by other agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
T48992APoisoning by other agents primarily acting on the respiratory system, intentional self-harm, initial encounter
T48993APoisoning by other agents primarily acting on the respiratory system, assault, initial encounter
T48994APoisoning by other agents primarily acting on the respiratory system, undetermined, initial encounter
T48995AAdverse effect of other agents primarily acting on the respiratory system, initial encounter
T490X1APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), initial encounter
T490X2APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter
T490X3APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, initial encounter
T490X4APoisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter
T490X5AAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T491X1APoisoning by antipruritics, accidental (unintentional), initial encounter
T491X2APoisoning by antipruritics, intentional self-harm, initial encounter
T491X3APoisoning by antipruritics, assault, initial encounter
T491X4APoisoning by antipruritics, undetermined, initial encounter
T491X5AAdverse effect of antipruritics, initial encounter
T492X1APoisoning by local astringents and local detergents, accidental (unintentional), initial encounter
T492X2APoisoning by local astringents and local detergents, intentional self-harm, initial encounter
T492X3APoisoning by local astringents and local detergents, assault, initial encounter
T492X4APoisoning by local astringents and local detergents, undetermined, initial encounter



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244
08 Mar 2024 10:29:37
CMS, code-revision=359, description-revision=1383